Skip to main content
UCB logo

UCB — Investor Relations & Filings

Ticker · UCB ISIN · BE0003739530 LEI · 2138008J191VLSGY5A09 BR Manufacturing
Filings indexed 2,023 across all filing types
Latest filing 2020-04-23 Transaction in Own Shar…
Country BE Belgium
Listing BR UCB

UCB is a global biopharmaceutical company that focuses on creating solutions for people living with severe diseases, primarily in the fields of neurology and immunology. The company's core activities include the research, development, and commercialization of pharmaceutical and biotechnology products. Guided by a patient-centric and science-driven approach, UCB is committed to innovation and sustainability. Through its UCB Ventures arm, it invests in pioneering technologies and companies with the potential to transform patient care. The company also offers personalized support services to patients and healthcare professionals during their treatment journey with a UCB medicine.

Recent filings

Filing Released Lang Actions
23-04-20-EN.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details transactions where UCB NV bought back its own shares (Aandelen Inkoopprogramma 2020) and disposed of shares related to employee stock option plans during April 2020. This activity directly corresponds to the definition of a company reporting on transactions involving its own shares, which maps precisely to the 'Transaction in Own Shares' category.
2020-04-23 English
23-04-20-FR.pdf
Transaction in Own Shares Classification · 99% confidence The document is titled "Rachat et Aliénation d'actions propres" (Share Repurchase and Disposal) and details transactions where UCB SA repurchased its own shares (Rachat d'actions propres) and disposed of shares related to employee stock options (Aliénation d'actions propres) between April 14 and April 22, 2020. This activity directly corresponds to the definition of 'Transaction in Own Shares' (POS), which covers share repurchase or issuance activities by the company. The document is a formal regulatory announcement ('information réglementée') detailing these specific transactions, not a general earnings report or a proxy statement.
2020-04-23 French
23-04-20-NL.pdf
Transaction in Own Shares Classification · 99% confidence The document explicitly details 'Acquisitions of own shares' and 'Disposals of own shares' conducted by UCB SA/NV under its Share Repurchase Program 2020, providing specific dates, quantities, and prices for transactions occurring between April 14 and April 22, 2020. This activity directly corresponds to the definition of a company reporting on buying back or selling its own shares. This matches the 'Transaction in Own Shares' category (POS). It is not an Earnings Release (ER), Interim Report (IR), or Annual Report (10-K), as it focuses solely on treasury stock movements.
2020-04-23 Dutch
20200410 UCB Acquisitions and disposals of own shares.pdf
Transaction in Own Shares Classification · 100% confidence The document explicitly details 'Acquisitions of own shares' and 'Disposals of own shares' conducted by UCB SA/NV between April 3, 2020, and April 9, 2020, as part of its Share Repurchase Program 2020. This activity directly relates to the company buying back or selling its own shares. This matches the definition for 'Transaction in Own Shares' (POS). The document is a press release announcing these transactions, not a comprehensive annual or interim report.
2020-04-10 English
20200410 - Rachat et Aliénation d'actions propres.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Rachat et Aliénation d'actions propres" (Repurchase and Disposal of Own Shares) and details transactions where UCB SA bought back its own shares (Rachat d'actions propres) and disposed of shares related to employee stock option plans (Aliénation d'actions propres) between April 3 and April 9, 2020. This activity directly relates to the company managing its own stock holdings, which falls under the definition of 'Transaction in Own Shares' (POS). It is not a general earnings release (ER), a full annual report (10-K), or a management discussion (MDA). The specific nature of reporting share repurchases/disposals strongly points to the POS code.
2020-04-10 French
20200410 Verwerving en vervreemding van eigen aandelen.pdf
Transaction in Own Shares Classification · 100% confidence The document is titled "Verwerving en vervreemding van eigen aandelen" (Acquisition and disposal of own shares) and details transactions where UCB NV bought back its own shares (Aandelen Inkoopprogramma 2020) and disposed of shares related to employee incentive plans. This activity directly relates to the company's share capital management and transactions involving its own stock. This aligns perfectly with the definition for 'Transaction in Own Shares' (POS). The document is a formal announcement ('gereglementeerde informatie') detailing specific transactions over a period (April 3 to April 9, 2020), not just an announcement that a report is forthcoming.
2020-04-10 Dutch

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.